Sertraline Hydrochloride Tablet Market

Sertraline hydrochloride tablets are indicated for the treatment of symptoms related to depression, including depression with anxiety, with or without a history of mania.

Sertraline Hydrochloride Tablet Market contains market size and forecasts of Sertraline Hydrochloride Tablet in global, including the following market information:

Global Sertraline Hydrochloride Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Sertraline Hydrochloride Tablet Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Sertraline Hydrochloride Tablet companies in 2021 (%)

The global Sertraline Hydrochloride Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Generic Grugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sertraline Hydrochloride Tablet include PIDI, Cy Pharm, HENGSHAN PHARMACEYTICAL, JINGXIN PHARMACEUTICAL, Hainan Healthcare Pharma, Pfizer, Accord-Healthcare., Exelan Pharmaceuticals and Greenstone, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Sertraline Hydrochloride Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sertraline Hydrochloride Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sertraline Hydrochloride Tablet Market Segment Percentages, by Type, 2021 (%)

• Generic Grugs
• Patent Medicine
• Others

Global Sertraline Hydrochloride Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sertraline Hydrochloride Tablet Market Segment Percentages, by Application, 2021 (%)

• Treat Depression
• Treat Obsessive-Compulsive Disorder
• Treat Anxiety
• Others

Global Sertraline Hydrochloride Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sertraline Hydrochloride Tablet Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Sertraline Hydrochloride Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Sertraline Hydrochloride Tablet revenues share in global market, 2021 (%)
• Key companies Sertraline Hydrochloride Tablet sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Sertraline Hydrochloride Tablet sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• PIDI
• Cy Pharm
• HENGSHAN PHARMACEYTICAL
• JINGXIN PHARMACEUTICAL
• Hainan Healthcare Pharma
• Pfizer
• Accord-Healthcare.
• Exelan Pharmaceuticals
• Greenstone
• Cipla USA Lnc
• Lupin